IL249174A0 - Genetic alterations associated with autism and autistic phenotype and methods of diagnosing and treating autism - Google Patents

Genetic alterations associated with autism and autistic phenotype and methods of diagnosing and treating autism

Info

Publication number
IL249174A0
IL249174A0 IL249174A IL24917416A IL249174A0 IL 249174 A0 IL249174 A0 IL 249174A0 IL 249174 A IL249174 A IL 249174A IL 24917416 A IL24917416 A IL 24917416A IL 249174 A0 IL249174 A0 IL 249174A0
Authority
IL
Israel
Prior art keywords
autism
diagnosing
methods
genetic alterations
alterations associated
Prior art date
Application number
IL249174A
Other languages
Hebrew (he)
Original Assignee
The Children's Hospital Of Philadelphia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/292,480 external-priority patent/US20160244831A9/en
Application filed by The Children's Hospital Of Philadelphia filed Critical The Children's Hospital Of Philadelphia
Publication of IL249174A0 publication Critical patent/IL249174A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL249174A 2014-05-30 2016-11-24 Genetic alterations associated with autism and autistic phenotype and methods of diagnosing and treating autism IL249174A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14/292,480 US20160244831A9 (en) 2011-07-07 2014-05-30 Genetic Alterations Associated with Autism and the Autistic Phenotype and Methods of Use Thereof for the Diagnosis and Treatment of Autism
US201414131359A 2014-07-10 2014-07-10
PCT/US2015/042354 WO2016022324A1 (en) 2014-05-30 2015-07-28 Genetic alterations associated with autism and autistic phenotype and methods of diagnosing and treating autism

Publications (1)

Publication Number Publication Date
IL249174A0 true IL249174A0 (en) 2017-01-31

Family

ID=55264338

Family Applications (1)

Application Number Title Priority Date Filing Date
IL249174A IL249174A0 (en) 2014-05-30 2016-11-24 Genetic alterations associated with autism and autistic phenotype and methods of diagnosing and treating autism

Country Status (5)

Country Link
EP (1) EP3149211A1 (en)
AU (1) AU2015298618A1 (en)
IL (1) IL249174A0 (en)
SG (1) SG11201609832XA (en)
WO (1) WO2016022324A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2609220B1 (en) 2010-08-24 2018-06-27 The Children's Hospital of Philadelphia Association of rare recurrent genetic variations to attention-deficit, hyperactivity disorder (adhd) and methods of use thereof for the diagnosis and treatment of the same
US11219617B2 (en) 2014-05-30 2022-01-11 The Children's Hospital Of Philadelphia Methods of diagnosing and treating autism
US11179378B2 (en) 2015-09-08 2021-11-23 The Children's Hospital Of Philadelphia Methods of diagnosing and treating conduct disorder
CN109082473A (en) * 2018-10-16 2018-12-25 兰州大学 The detection method and application of one breeding oxen ZNF280AY gene copy number variation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1152756B1 (en) * 1999-02-08 2005-07-13 Ortho-McNeil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating autism
US20070292962A1 (en) * 2006-04-10 2007-12-20 Duke University Methods and compositions for genetic markers for autism
CA2766246C (en) * 2008-11-14 2020-03-10 Hakon Hakonarson Genetic variants underlying human cognition and methods of use thereof as diagnostic and therapeutic targets

Also Published As

Publication number Publication date
SG11201609832XA (en) 2016-12-29
AU2015298618A1 (en) 2016-12-08
EP3149211A1 (en) 2017-04-05
WO2016022324A1 (en) 2016-02-11

Similar Documents

Publication Publication Date Title
HK1253093A1 (en) Methods of diagnosing and treating cancer
IL290994A (en) Methods of diagnosing and treating conduct disorder
PL3297644T3 (en) Methods for treating autism spectrum disorder and associated symptoms
GB2552267B (en) Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
PL3119892T3 (en) Beta-hexosaminidase protein variants and associated methods for treating gm2 gangliosdoses
AP2016009549A0 (en) Methods for increasing red blood cell levels and treating sickle-cell disease
HK1248552A1 (en) Method of treatment with tradipitant
HK1253348A1 (en) Methods and processes for non-invasive assessment of genetic variations
HK1232235A1 (en) Methods of treating and diagnosing alpha-v-beta-6 overexpressing cancer -v--6
SG11201704177SA (en) Methods and apparatuses for gene purification and imaging
GB201401773D0 (en) Incubator apparatus and methods
IL254963A0 (en) Compositions and methods for treating autism
EP3307913A4 (en) Methods of diagnosing and treating autism
IL249174A0 (en) Genetic alterations associated with autism and autistic phenotype and methods of diagnosing and treating autism
SG10201500174SA (en) Led testing process and correction methods therefor
HK1249866A1 (en) Methods of treatment with taselisib
IL248080A0 (en) System and method of identifying sources associated with biological rhythm disorders
ZA201608306B (en) Methods of diagnosing and treating tuberculosis
SG11201610008WA (en) Composite media for water treatment processes and methods of using same
HK1244511A1 (en) Diagnosis and treatment of genetic alterations associated with eosinophilic esophagitis
IL267231A (en) Methods of treating diseases associated with ilc2 cells
IL262951A (en) Methods of treating diseases associated with ilc3 cells
GB201400311D0 (en) Treating Susceptibility
GB201401774D0 (en) Incubator apparatus and methods
GB201401806D0 (en) Novel methods for diagnosis and therapy